These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2401272)

  • 1. Inhalation pharmacokinetics of 1,3-butadiene and 1,2-epoxybutene-3 in rats and mice.
    Laib RJ; Filser JG; Kreiling R; Vangala RR; Bolt HM
    Environ Health Perspect; 1990 Jun; 86():57-63. PubMed ID: 2401272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalation pharmacokinetics of 1,2-epoxybutene-3 reveal species differences between rats and mice sensitive to butadiene-induced carcinogenesis.
    Kreiling R; Laib RJ; Filser JG; Bolt HM
    Arch Toxicol; 1987; 61(1):7-11. PubMed ID: 3439877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in butadiene metabolism between mouse and rat.
    Laib RJ; Filser JG; Kreiling R
    Ann N Y Acad Sci; 1988; 534():663-70. PubMed ID: 3389683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interspecies differences in metabolism and kinetics of 1,3-butadiene, isobutene and styrene.
    Bolt HM
    IARC Sci Publ; 1993; (127):37-44. PubMed ID: 8070883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice.
    Himmelstein MW; Turner MJ; Asgharian B; Bond JA
    Toxicology; 1996 Oct; 113(1-3):306-9. PubMed ID: 8901914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species differences in butadiene metabolism between mice and rats evaluated by inhalation pharmacokinetics.
    Kreiling R; Laib RJ; Filser JG; Bolt HM
    Arch Toxicol; 1986 Apr; 58(4):235-8. PubMed ID: 3718226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epoxybutene-hemoglobin adducts in rats and mice: dose response for formation and persistence during and following long-term low-level exposure to butadiene.
    Osterman-Golkar SM; Moss O; James A; Bryant MS; Turner M; Bond JA
    Toxicol Appl Pharmacol; 1998 May; 150(1):166-73. PubMed ID: 9630466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalation pharmacokinetics of isoprene in rats and mice.
    Peter H; Wiegand HJ; Filser JG; Bolt HM; Laib RJ
    Environ Health Perspect; 1990 Jun; 86():89-92. PubMed ID: 2401276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic and germ cell effects in rats and mice after treatment with 1,3-butadiene and its metabolites, 1,2-epoxybutene and 1,2,3,4-diepoxybutane.
    Anderson D; Dobrzyńka MM; Jackson LI; Yu TW; Brinkworth MH
    Mutat Res; 1997 Jul; 391(3):233-42. PubMed ID: 9268048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation.
    Johanson G; Filser JG
    Arch Toxicol; 1993; 67(3):151-63. PubMed ID: 8494494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene.
    Himmelstein MW; Asgharian B; Bond JA
    Toxicol Appl Pharmacol; 1995 Jun; 132(2):281-8. PubMed ID: 7785055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
    Motwani HV; Törnqvist M
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose responses for DNA adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-[(14)C]-butadiene.
    Booth ED; Kilgour JD; Robinson SA; Watson WP
    Chem Biol Interact; 2004 Mar; 147(2):195-211. PubMed ID: 15013821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of hepatic non-protein sulfhydryl content during exposure of rats and mice to butadiene.
    Kreiling R; Laib RJ; Bolt HM
    Toxicol Lett; 1988 Jun; 41(3):209-14. PubMed ID: 3376148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,3-Butadiene: toxicity and carcinogenicity in laboratory animals and in humans.
    Melnick RL; Huff J
    Rev Environ Contam Toxicol; 1992; 124():111-44. PubMed ID: 1732994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures.
    Thornton-Manning JR; Dahl AR; Allen ML; Bechtold WE; Griffith WC; Henderson RF
    Toxicol Sci; 1998 Feb; 41(2):167-73. PubMed ID: 9520352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene.
    Nauhaus SK; Fennell TR; Asgharian B; Bond JA; Sumner SC
    Chem Res Toxicol; 1996 Jun; 9(4):764-73. PubMed ID: 8831821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhalation pharmacokinetics based on gas uptake studies. V. Comparative pharmacokinetics of ethylene and 1,3-butadiene in rats.
    Bolt HM; Filser JG; Störmer F
    Arch Toxicol; 1984 Oct; 55(4):213-8. PubMed ID: 6517696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of haemoglobin adducts for biomonitoring exposure to 1,3-butadiene.
    Osterman-Golkar SM; Bond JA; Ward JB; Legator MS
    IARC Sci Publ; 1993; (127):127-34. PubMed ID: 8070858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.